CSF3 and Decreased total neutrophil count: Grade ≥3 treatment-related neutropenia was seen in 61% of SG-treated patients, but febrile neutropenia in only one patient (grade 4); 58% of patients received concomitant granulocyte colony-stimulating factor (GCSF).